Core Insights - The core viewpoint emphasizes that data is fundamental, AI technology is the driving force for development, and commercialization is the ultimate goal in AI healthcare [2][5]. Group 1: AI Technology in Healthcare - The company, as a leading online professional doctor platform, has over 7 million registered users, with more than 4 million being licensed physicians, covering 88% of the physician community in China [3]. - The company has developed a medical vertical large model through independent research and has received approval from the National Internet Information Office, enabling intelligent clinical decision support for doctors [3]. - AI products have demonstrated significant value, providing traceable answers to clinical questions, ensuring information accuracy and reliability for physicians [3]. Group 2: Business Model and Commercialization - The company focuses on the pharmaceutical and medical device sectors, particularly in prescription drug markets, to conduct targeted academic education for doctors [5]. - The core logic of the business model is to leverage strong physician resources to enhance the efficiency of academic marketing and provide professional academic support to doctors [5]. - The company has achieved over 30% annual revenue growth and maintains a strong net profit margin, supporting ongoing investments in AI technology [5]. Group 3: Future Development and Industry Impact - The company has established a virtuous cycle between AI technology and commercial applications, contributing to the digital transformation of the healthcare industry [5].
医脉通投资者关系负责人胡慧楠：深耕医生服务平台，以AI技术赋能医疗专业生态｜聚焦2025华夏大健康